Tags

Type your tag names separated by a space and hit enter

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.
Laryngoscope 2009; 119(8):1542-9L

Abstract

OBJECTIVES/HYPOTHESIS

The human papillomavirus (HPV) has been identified as a causative factor in 20% to 25% of all head and neck squamous cell carcinomas (HNSCC). Ongoing research suggests that the presence of HPV DNA in HNSCC predicts a positive prognosis with respect to disease-free and overall survival. However, most studies have been limited by the heterogeneity in treatment regimens and/or anatomic subsites of tumor origin. In this study, we correlate clinical outcomes with HPV status for patients with oropharyngeal carcinomas who were uniformly treated with a concurrent chemoradiation treatment protocol.

STUDY DESIGN

Retrospective study.

METHODS

Demographic and clinicopathologic parameters, including age at diagnosis, gender, race, smoking and alcohol history, tumor stage and grade, locoregional recurrence, metastatic spread, recurrence-free survival, overall survival and disease-specific death, were obtained from medical charts and established databases. These parameters were correlated with HPV status of the tumors established by in situ hybridization analysis.

RESULTS

HPV positivity correlated with improved clinical outcomes regarding locoregional control (P = .042), recurrence-free survival (P = .009), overall survival (P = .017), and disease-specific death (P = .09). Advanced T stage was a significant risk factor for recurrence and death independent of HPV status.

CONCLUSIONS

In patients with oropharyngeal carcinoma uniformly treated with chemoradiation, the presence of HPV is a favorable prognostic indicator with respect to recurrence and overall survival. However, advanced T stage was an independent risk factor for recurrence and death that can to some degree offset this benefit.

Authors+Show Affiliations

Department of Otolaryngology/Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19522004

Citation

Sedaghat, Ahmad R., et al. "Prognostic Significance of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinomas." The Laryngoscope, vol. 119, no. 8, 2009, pp. 1542-9.
Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope. 2009;119(8):1542-9.
Sedaghat, A. R., Zhang, Z., Begum, S., Palermo, R., Best, S., Ulmer, K. M., ... Pai, S. I. (2009). Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. The Laryngoscope, 119(8), pp. 1542-9. doi:10.1002/lary.20533.
Sedaghat AR, et al. Prognostic Significance of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinomas. Laryngoscope. 2009;119(8):1542-9. PubMed PMID: 19522004.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. AU - Sedaghat,Ahmad R, AU - Zhang,Zhe, AU - Begum,Shahnaz, AU - Palermo,Robert, AU - Best,Simon, AU - Ulmer,Karen M, AU - Levine,Marshall, AU - Zinreich,Eva, AU - Messing,Barbara P, AU - Gold,Dorothy, AU - Wu,Annie A, AU - Niparko,Kevin J, AU - Kowalski,Jeanne, AU - Hirata,Richard M, AU - Saunders,John R, AU - Westra,William H, AU - Pai,Sara I, PY - 2009/6/13/entrez PY - 2009/6/13/pubmed PY - 2009/8/29/medline SP - 1542 EP - 9 JF - The Laryngoscope JO - Laryngoscope VL - 119 IS - 8 N2 - OBJECTIVES/HYPOTHESIS: The human papillomavirus (HPV) has been identified as a causative factor in 20% to 25% of all head and neck squamous cell carcinomas (HNSCC). Ongoing research suggests that the presence of HPV DNA in HNSCC predicts a positive prognosis with respect to disease-free and overall survival. However, most studies have been limited by the heterogeneity in treatment regimens and/or anatomic subsites of tumor origin. In this study, we correlate clinical outcomes with HPV status for patients with oropharyngeal carcinomas who were uniformly treated with a concurrent chemoradiation treatment protocol. STUDY DESIGN: Retrospective study. METHODS: Demographic and clinicopathologic parameters, including age at diagnosis, gender, race, smoking and alcohol history, tumor stage and grade, locoregional recurrence, metastatic spread, recurrence-free survival, overall survival and disease-specific death, were obtained from medical charts and established databases. These parameters were correlated with HPV status of the tumors established by in situ hybridization analysis. RESULTS: HPV positivity correlated with improved clinical outcomes regarding locoregional control (P = .042), recurrence-free survival (P = .009), overall survival (P = .017), and disease-specific death (P = .09). Advanced T stage was a significant risk factor for recurrence and death independent of HPV status. CONCLUSIONS: In patients with oropharyngeal carcinoma uniformly treated with chemoradiation, the presence of HPV is a favorable prognostic indicator with respect to recurrence and overall survival. However, advanced T stage was an independent risk factor for recurrence and death that can to some degree offset this benefit. SN - 1531-4995 UR - https://www.unboundmedicine.com/medline/citation/19522004/Prognostic_significance_of_human_papillomavirus_in_oropharyngeal_squamous_cell_carcinomas_ L2 - https://doi.org/10.1002/lary.20533 DB - PRIME DP - Unbound Medicine ER -